Navigation Links
US mammograms decline after task force recommendation, Mayo Clinic finds
Date:6/26/2012

ROCHESTER, Minn. -- Preventive mammography rates in women in their 40s have dropped nearly 6 percent nationwide since the U.S. Preventive Services Task Force (USPSTF) recommended against routine mammograms for women in this age group, a Mayo Clinic analysis shows. That represents a small but significant decrease since the controversial guidelines were released, the researchers say. Their findings are being presented at the Academy Health Annual Research Meeting, June 24-26, in Orlando, Fla.

"The 2009 USPSTF guidelines resulted in significant backlash among patients, physicians and other organizations, prompting many medical societies to release opposing guidelines," says co-author Nilay Shah, Ph.D., a researcher at the Mayo Clinic Center for the Science of Health Care Delivery. "We were interested in determining the impact that the recommendations and subsequent public debate had upon utilization of mammography in younger women."

Using a large, national representative database of 100 health plans, researchers identified the number of screening mammograms performed between January 2006 and December 2010, and compared rates before and after the task force report. Nearly 8 million women ages 40 to 64 were included in the analysis.

Comparing mammography rates before and after publication of the new guidelines, researchers found that the recommendations were associated with a 5.72 percent decrease in the mammography rate for women ages 40-49. Over a year, nearly 54,000 fewer mammograms were performed in this age group.

"For the first year after the guidelines changed, there was a small but significant decrease in the rate of mammography for women ages 40󈞝," Dr. Shah says. "This is consistent with the context of the guidelines change. A modest effect is also in line with the public resistance to the guidelines change and the subsequent release of conflicting guidelines."

Mammography Screening: What Mayo Clinic Recommends

Mayo Clinic continues to recommend an annual screening mammogram beginning at age 40, in line with recommendations from the American Cancer Society. Mayo uses a three-tiered approach:

  • Breast health awareness, which includes a woman becoming familiar with her breasts to identify breast abnormalities or changes and to inform her doctor of any changes that may need further evaluation.
  • A clinical breast exam performed by a health care provider and recommended annually beginning at age 40.
  • Screening mammography beginning at age 40.

Screening mammograms can detect breast abnormalities early in women in their 40s. Findings from a large study in Sweden of more than 1 million women in their 40s who received screening mammograms showed a 29 percent decline in breast cancer deaths.

"Screening mammography is not a perfect exam, but it is the best available tool to detect cancer early," says Sandhya Pruthi, M.D., director of Mayo Clinic's Breast Clinic. "Early detection can lead to better options and possibly less-aggressive treatments."


'/>"/>

Contact: Shelly Plutowski
newsbureau@mayo.edu
507-284-5005
Mayo Clinic
Source:Eurekalert

Related medicine news :

1. Mammograms Beat Thermography for Breast Cancer Detection: Study
2. No family history not a good reason for women 40-49 to stop yearly screening mammograms
3. Here Are the Women Who Need Mammograms in Their 40s: Study
4. Routine mammograms may result in significant overdiagnosis of invasive breast cancer
5. Preventing or better managing diabetes may prevent cognitive decline, according to UCSF study
6. Hospitalization May Be Tipping Point for Alzheimers Decline
7. Diabetes May Hasten Mental Decline
8. CNIO scientists successfully test the first gene therapy against aging-associated decline
9. Rate of Hospitalizations for Stroke Has Declined in U.S.
10. Stress contributes to cognitive declines in women with breast cancer, researcher says
11. Brain Falters Near End of Life, but Games, Puzzles Might Slow Decline
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2017)... Peoria, IL (PRWEB) , ... May 22, 2017 ... ... HealthCare, is part of a larger group investing in InsightRX, an early stage ... a patient’s underlying biological and pharmacological characteristics. Greatpoint Ventures Innovation Fund ...
(Date:5/21/2017)... FL (PRWEB) , ... May 20, 2017 , ... Pot. ... it, find it, review it, and share its attributes like never before. More than ... directory to connect cannabis enthusiasts to stores, strains, products – and for the first ...
(Date:5/21/2017)... ... May 21, 2017 , ... ... longer than six months since you've seen a dentist, it's time for a ... and getting x-rays once per year. , Dental checkups are a relatively easy ...
(Date:5/19/2017)... ... May 19, 2017 , ... Springfield, Vermont-based law firm ... Titled " Ten Good Reasons To Hire An Experienced Personal Injury Attorney, " the ... an accident or injury. As the article says. if someone is injured due ...
(Date:5/19/2017)... ... 19, 2017 , ... As a groundbreaking surgeon on the frontline of prostate ... screenings. Early detection of the disease, he says, can make a world of difference. ... , stands alongside the Georgia Comprehensive Cancer Control’s (GC3) Prostate Cancer Task Force and ...
Breaking Medicine News(10 mins):
(Date:5/22/2017)...  As the specialty pharmacy industry and the ... the revolutionary shift from volume-based to value-based care, ... patient outcomes and shaping the future of the ... from clinical trials and toward data that reveals ... therapy utilization in precise patient populations. Therigy ® ...
(Date:5/18/2017)...  Bayer announced today that the latest research from ... the 53 rd Annual Meeting of the American ... in Chicago . ... liver and thyroid cancers, as well as lymphomas, and ... trial of copanlisib in patients with relapsed or refractory ...
(Date:5/15/2017)... 2017 Enterin Inc., a privately-held CNS pharmaceutical company ... compounds to treat Parkinson,s disease (PD), has enrolled the first ... 1/2a randomized, controlled, multicenter study involving patients with PD and ... patients over a 9-to-12-month period. The first stage is open ... PD. Participating sites include Denver , ...
Breaking Medicine Technology: